It is also my understanding that Actavis can launch 'at risk' when the 30-month stay expire in Oct. But what if Teva is the exclusivity holder and gets approved tomorrow? the language in the link you've posted implies that Teva is the '1st to file'. And of course as you've noted a settlement is another possibility.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.